Skip to main content

Advertisement

SpringerLink
Log in

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

  • Review Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Summary.

Short CCK peptides elicit panic attacks in humans and anxiogenic-like effects in some animal models, but CCK receptor antagonists have not been found clinically effective. Yet CCK overactivity appears to be involved in submissive behaviour, and CCKB receptor expression and binding are increased in suicide victims and animal models of anxiety. Preliminary data suggest that involvement of CCK and its receptor subtypes in anxiety can be better described when focusing on distinct endophenotypes, and considering environmental contingencies and confounds originating from interactions with dopamin-, opioid- and glutamatergic neurotransmission. In contrast, NPY is an anti-anxiety peptide with robust effects in various animal models when administrated into several brain regions. Studies with non-peptide antagonists selective for receptor subtypes have revealed the role of endogenous NPY in active coping. At least Y1, Y2 and Y5 receptors in various brain regions are involved, with the strongest evidence for contribution of Y1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • JL Abelson RM Nesse A Vinik (1991) ArticleTitleStimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder Biol Psychiatry 29 1220–1223 Occurrence Handle1653622 Occurrence Handle1:STN:280:DyaK3MzmtlCqsw%3D%3D

    PubMed  CAS  Google Scholar 

  • RE Adamec T Shallow J Budgell (1997) ArticleTitleBlockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder Behav Neurosci 111 435–449 Occurrence Handle9106682 Occurrence Handle1:CAS:528:DyaK2sXls1Sms7s%3D

    PubMed  CAS  Google Scholar 

  • JB Adams RE Pyke J Costa NR Cutler E Schweizer CS Wilcox PG Wisselink M Greiner MW Pierce A Pande (1995) ArticleTitleA double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder J Clin Psychopharmacol 15 428–434 Occurrence Handle8748432 Occurrence Handle1:STN:280:DyaK28zltlSgtQ%3D%3D

    PubMed  CAS  Google Scholar 

  • J Akiyoshi T Moriyama K Isogawa M Miyamoto I Sasaki K Kuga H Yamamoto K Yamada I Fujii (1996) ArticleTitleCCK-4-induced calcium mobilization in T cells is enhanced in panic disorder J Neurochem 66 1610–1616 Occurrence Handle8627317 Occurrence Handle1:CAS:528:DyaK28XhslGhsL4%3D Occurrence Handle10.1046/j.1471-4159.1996.66041610.x

    Article  PubMed  CAS  Google Scholar 

  • H Alho E Costa P Ferrero M Fujimoto D Cosenza-Murphy A Guidotti (1985) ArticleTitleDiazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain Science 229 179–182 Occurrence Handle3892688 Occurrence Handle1:CAS:528:DyaL2MXks1CrsL8%3D

    PubMed  CAS  Google Scholar 

  • A Alttoa J Harro (2004) ArticleTitleEffect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behaviour and sensitization to amphetamine Eur Neuropsychopharmacol 14 324–331 Occurrence Handle15163443 Occurrence Handle1:CAS:528:DC%2BD2cXktF2ktb0%3D

    PubMed  CAS  Google Scholar 

  • A Aluoja J Shlik V Vasar PH Kingisepp K Jagomägi E Vasar J Bradwejn (1997) ArticleTitleEmotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers Psychiatry Res 66 59–67 Occurrence Handle9061804 Occurrence Handle1:CAS:528:DyaK2sXhvFOkt7k%3D

    PubMed  CAS  Google Scholar 

  • J Andre B Zeau M Pohl F Cesselin J-J Benoliel C Becker (2005) ArticleTitleInvolvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies J Neurosci 25 7896–7904 Occurrence Handle16135746 Occurrence Handle1:CAS:528:DC%2BD2MXhtVaktrbL

    PubMed  CAS  Google Scholar 

  • C Becker M Hamon J-J Benoliel (1999) ArticleTitlePrevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat Neuropharmacology 38 525–532 Occurrence Handle10221756 Occurrence Handle1:CAS:528:DyaK1MXitlGks7g%3D

    PubMed  CAS  Google Scholar 

  • C Becker M-H Thiébot Y Touitou M Hamon F Cesselin JJ Benoliel (2001) ArticleTitleEnhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat J Neurosci 21 262–269 Occurrence Handle11150343 Occurrence Handle1:CAS:528:DC%2BD3MXmtVOntg%3D%3D

    PubMed  CAS  Google Scholar 

  • MC Beinfeld DK Meyer RL Eskay RT Jensen MJ Brownstein (2001) ArticleTitleThe distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay Brain Res 212 51–57

    Google Scholar 

  • I Belcheva S Belcheva VV Petkov VD Petkov (1994) ArticleTitleAsymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala Neuropharmacology 33 995–1002 Occurrence Handle7845556 Occurrence Handle1:CAS:528:DyaK2cXmt1amtrc%3D

    PubMed  CAS  Google Scholar 

  • B Bellier D Crété M-E Million F Beslot A Bado A Garbay V Daugé (2004) ArticleTitleNew CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterization of BBL454 Naunyn-Schmiedeberg’s Arch Pharmacol 370 404–413 Occurrence Handle1:CAS:528:DC%2BD2cXps1Wqur0%3D

    CAS  Google Scholar 

  • C Benkelfat J Bradwejn E Meyer M Ellenbogen S Milot A Gjedde A Evans (1995) ArticleTitleFunctional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers Am J Psychiatry 152 1180–1184 Occurrence Handle7625467 Occurrence Handle1:STN:280:DyaK2MzltFeqtw%3D%3D

    PubMed  CAS  Google Scholar 

  • S Bhatnagar V Viau A Chu L Soriano OC Meijer MF Dallman (2000) ArticleTitleA cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function J Neurosci 20 5564–5573 Occurrence Handle10884340 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Whsrg%3D

    PubMed  CAS  Google Scholar 

  • MJ Bickerdike CA Marsden CT Dourish A Fletcher (1994) ArticleTitleThe influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze Eur J Pharmacol 271 403–411 Occurrence Handle7705440 Occurrence Handle1:CAS:528:DyaK2MXjt1SntLo%3D

    PubMed  CAS  Google Scholar 

  • M Bourin E Dailly (2004) ArticleTitleCholecystokinin and panic disorder Acta Neuropsych 16 85–93

    Google Scholar 

  • J Bradwejn C de Montigny (1984) ArticleTitleBenzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurons Nature 312 363–364 Occurrence Handle6095093 Occurrence Handle1:CAS:528:DyaL2MXlsF2qug%3D%3D

    PubMed  CAS  Google Scholar 

  • J Bradwejn D Koszycki M Bourin (1991a) ArticleTitleDose ranging study of the effect of CCK4 in healthy volunteers J Psychiatry Neurosci 16 230–234

    Google Scholar 

  • J Bradwejn D Koszycki A Couetoux-du-Tertre H van Megen J den Boer H Westenberg (1994) ArticleTitleL-365,260: A CCK-B antagonist blocks CCK4-panic in panic disorder Arch Gen Psychiatry 51 486–493 Occurrence Handle8192551 Occurrence Handle1:STN:280:DyaK2c3ltVWjtQ%3D%3D

    PubMed  CAS  Google Scholar 

  • J Bradwejn D Koszycki G Meterissian (1990) ArticleTitleCholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder Can J Psychiatry 35 83–85 Occurrence Handle2180549 Occurrence Handle1:STN:280:DyaK3c7pvFKhuw%3D%3D

    PubMed  CAS  Google Scholar 

  • J Bradwejn D Koszycki C Shriqui (1991b) ArticleTitleEnhanced sensitivity to cholecystokinin tetrapeptide in panic disorder Arch Gen Psychiatry 48 603–610 Occurrence Handle1:STN:280:DyaK3M3pvVygug%3D%3D

    CAS  Google Scholar 

  • KT Britton S Southerland E Van Uden D Kirby J Rivier G Koob (1997) ArticleTitleAnxiolytic activity of NPY receptor agonists in the conflict test Psychopharmacology 132 6–13 Occurrence Handle9272753 Occurrence Handle1:CAS:528:DyaK2sXkvFKjt7Y%3D

    PubMed  CAS  Google Scholar 

  • K Brodin S-O Ögren E Brodin (1994) ArticleTitleClomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions Eur J Pharmacol 263 175–180 Occurrence Handle7529711 Occurrence Handle1:CAS:528:DyaK2cXmsVKitLs%3D

    PubMed  CAS  Google Scholar 

  • P Broqua JG Wettstein MN Rocher JL Gauthier-Martin JL Junien (1995) ArticleTitleBehavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures Behav Pharmacol 6 215–222 Occurrence Handle11224329 Occurrence Handle1:CAS:528:DyaK2MXlslCmt78%3D

    PubMed  CAS  Google Scholar 

  • J Burgdorf J Panksepp MC Beinfeld RA Kroes JR Moskal (2006) ArticleTitleRegional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats Peptides 27 172–177 Occurrence Handle16143427 Occurrence Handle1:CAS:528:DC%2BD28Xktl2huw%3D%3D

    PubMed  CAS  Google Scholar 

  • M Buyse A Bado V Daugé (2001) ArticleTitleLeptin decreases feeding and exploratory behaviour via interactions with CCK1 receptors in the rat Neuropharmacology 40 818–825 Occurrence Handle11369035 Occurrence Handle1:CAS:528:DC%2BD3MXjtleqtLY%3D

    PubMed  CAS  Google Scholar 

  • Q Chen A Nakajima C Meacham Y-P Tang (2006) ArticleTitleElevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse Proc Natl Acad Sci USA 103 3881–3886 Occurrence Handle16537459 Occurrence Handle1:CAS:528:DC%2BD28XivFWisbo%3D

    PubMed  CAS  Google Scholar 

  • EJ Chesler SG Wilson WR Lariviere SL Rodriquez-Zas JS Mogil (2002) ArticleTitleIdentification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive Neurosci Biobehav Rev 26 907–923 Occurrence Handle12667496

    PubMed  Google Scholar 

  • E Csonka M Fekete G Nagy M Szanto-Fekete G Feledyg B Penke K Kovacs (1988) Anxiogenic effect of cholecystokinin in rats B Penke A Török (Eds) Peptides Walter de Gruyter New York 249–252

    Google Scholar 

  • V Daugé M Pophillat D Crété S Melik-Parsadaniantz BP Roques (2003) ArticleTitleInvolvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory Neuroscience 118 19–23 Occurrence Handle12676133

    PubMed  Google Scholar 

  • V Daugé A Sebret F Beslot T Matsui BP Roques (2001) ArticleTitleBehavioral profile of CCK2 receptor-deficient mice Neuropsychopharmacology 25 690–698 Occurrence Handle11682252

    PubMed  Google Scholar 

  • GR Dawson NMJ Rupniak SD Iversen S Curnow S Tye KJ Stanhope MD Tricklebank (1995) ArticleTitleLack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs Psychopharmacology 121 109–117 Occurrence Handle8539335 Occurrence Handle1:CAS:528:DyaK2MXos1Wjtr0%3D

    PubMed  CAS  Google Scholar 

  • C De Montigny (1989) ArticleTitleCholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers Arch Gen Psychiatry 46 511–517 Occurrence Handle2730276 Occurrence Handle1:CAS:528:DyaK3MXkt1altbY%3D

    PubMed  CAS  Google Scholar 

  • Y Dumont D Jacques JA St-Pierre Y Tong R Parker H Herzog R Quirion (2000) Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains R Quirion A Björklund T Hökfelt (Eds) Handbook of chemical neuroanatomy NumberInSeries16 Elsevier Science London 375–475

    Google Scholar 

  • C Eva P Mele A Oberto G Panzica MG Pisu M Serra (2004) ArticleTitleNeuroanatomical and pharmacological evidence for a functional interaction between GABAergic and NPY-Y1 transmission in the amygdala of Y1R/LacZ transgenic mice Crit Rev Neurobiol 16 33–41 Occurrence Handle15581397 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGjsL%2FL

    PubMed  CAS  Google Scholar 

  • JM Farook YZ Zhu H Wang SM Moochhala L Lee PTH Wong (2001) ArticleTitleStrain differences in freezing behavior of PVG hooded and Sprague–Dawley rats: differential cortical expression of cholecystokinin2 receptors Neuroreport 12 2717–2720 Occurrence Handle11522954 Occurrence Handle1:CAS:528:DC%2BD3MXmvFKjtr8%3D

    PubMed  CAS  Google Scholar 

  • SO Fetissov AS Jacoby PR Brumovsky J Shine TP Iismaa T Hökfelt (2003) ArticleTitleAltered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice Epilepsia 44 1022–1033 Occurrence Handle12887433 Occurrence Handle1:CAS:528:DC%2BD3sXntVCltbw%3D

    PubMed  CAS  Google Scholar 

  • PW Frankland SA Josselyn J Bradwejn FJ Vaccarino JS Yeomans (1997) ArticleTitleActivation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat J Neurosci 17 1838–1847 Occurrence Handle9030642 Occurrence Handle1:CAS:528:DyaK2sXhtlOmsb4%3D

    PubMed  CAS  Google Scholar 

  • L-Y Fu C Acuna-Goycolea AN van den Pol (2004) ArticleTitleNeuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal systems J Neurosci 24 8741–8751 Occurrence Handle15470140 Occurrence Handle1:CAS:528:DC%2BD2cXovVOltbk%3D

    PubMed  CAS  Google Scholar 

  • L Giardino C Bettelli M Pozza L Calzá (1999) ArticleTitleRegulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor Brain Res 824 304–307 Occurrence Handle10196464 Occurrence Handle1:CAS:528:DyaK1MXitFWrt7w%3D

    PubMed  CAS  Google Scholar 

  • G Griebel (1999) ArticleTitleIs there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol Ther 82 1–61 Occurrence Handle10341356 Occurrence Handle1:CAS:528:DyaK1MXitF2jt7k%3D

    PubMed  CAS  Google Scholar 

  • EA Harper EP Griffin NP Shanley JW Black (1999) ArticleTitleAnalysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse or rat cerebral cortex Br J Pharmacol 126 1496–1503 Occurrence Handle10217545 Occurrence Handle1:CAS:528:DyaK1MXitlOlsrc%3D

    PubMed  CAS  Google Scholar 

  • J Harro R-A Kiivet A Lang E Vasar (1990a) ArticleTitleRats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics Behav Brain Res 39 63–71 Occurrence Handle1:CAS:528:DyaK3cXlt1KrsLc%3D

    CAS  Google Scholar 

  • J Harro A Lang E Vasar (1990b) ArticleTitleLong-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain Eur J Pharmacol 180 77–83 Occurrence Handle1:CAS:528:DyaK3cXksFagtbY%3D

    CAS  Google Scholar 

  • J Harro C Löfberg J Rehfeld L Oreland (1996) ArticleTitleCholecystokinin peptides and receptors in the rat brain during stress Naunyn-Schmiedeberg’s Arch Pharmacol 354 59–66 Occurrence Handle1:CAS:528:DyaK28Xks1Sltb4%3D

    CAS  Google Scholar 

  • J Harro J Marcusson L Oreland (1992) ArticleTitleAlterations in brain cholecystokinin receptors in suicide victims Eur Neuropsychopharmacol 2 57–63 Occurrence Handle1638175 Occurrence Handle1:CAS:528:DyaK3sXltVSg

    PubMed  CAS  Google Scholar 

  • J Harro L Oreland (2001) ArticleTitleDepression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus Brain Res Rev 38 79–128 Occurrence Handle11750928 Occurrence Handle1:CAS:528:DC%2BD3MXpt1amu7w%3D

    PubMed  CAS  Google Scholar 

  • J Harro L Oreland E Vasar J Bradwejn (1995) ArticleTitleImpaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation Eur Neuropsychopharmacol 5 447–455 Occurrence Handle8998396 Occurrence Handle1:CAS:528:DyaK2MXhtVSgsbvF

    PubMed  CAS  Google Scholar 

  • J Harro M Põld E Vasar (1990c) ArticleTitleAnxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment Naunyn-Schmiedeberg’s Arch Pharmacol 341 62–67 Occurrence Handle1:CAS:528:DyaK3cXhsFahs7s%3D

    CAS  Google Scholar 

  • J Harro M Põld E Vasar L Allikmets (1989) ArticleTitleThe role of CCK-8-ergic mechanisms in the regulation of emotional behaviour in rodents J Higher Nervous Activity 39 877–883 Occurrence Handle1:CAS:528:DyaK3cXkvFWgtw%3D%3D

    CAS  Google Scholar 

  • J Harro E Vasar (1991) ArticleTitleEvidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat Eur J Pharmacol 193 379–381 Occurrence Handle2055248 Occurrence Handle1:CAS:528:DyaK3MXhslyltb8%3D

    PubMed  CAS  Google Scholar 

  • J Harro E Vasar J Bradwejn (1993) ArticleTitleCholecystokinin in animal and human research on anxiety Trends Pharmacol Sci 14 244–249 Occurrence Handle8372405 Occurrence Handle1:CAS:528:DyaK3sXltlWltLY%3D

    PubMed  CAS  Google Scholar 

  • J Harro E Vasar D Koszycki J Bradwejn (1995) ArticleTitleCholecystokinin in panic and anxiety disorders Adv Biol Psychiatry 1 235–262

    Google Scholar 

  • ALO Hebb J-F Poulin SP Roach RM Zacharko G Drolet (2005) ArticleTitleCholecystokinin and endogenous opiod peptides: Interactive influence on pain, cognition, and emotion Prog Neuro-Psychopharmacol Biol Psychiatry 29 1225–1238 Occurrence Handle1:CAS:528:DC%2BD2MXht1Ghtb3E

    CAS  Google Scholar 

  • ALO Hebb RM Zacharko H Dominguez S Laforest M Gauthier C Levac G Drolet (2003) ArticleTitleChanges in brain cholecystokinin and anxiety-like behavior following exposure of mice to predator odor Neuroscience 116 539–551 Occurrence Handle12559109 Occurrence Handle1:CAS:528:DC%2BD3sXmsVerug%3D%3D

    PubMed  CAS  Google Scholar 

  • M Heilig (2004a) ArticleTitleBrain neuropeptide Y (NPY) system: a candidate target for treatment of anxiety, depression and alcohol dependence Drugs Future 29 137–147 Occurrence Handle1:CAS:528:DC%2BD2cXivF2kur0%3D

    CAS  Google Scholar 

  • M Heilig (2004b) ArticleTitleThe NPY system in stress, anxiety and depression Neuropeptides 38 213–224 Occurrence Handle1:CAS:528:DC%2BD2cXntVOjsbw%3D

    CAS  Google Scholar 

  • M Heilig GF Koob R Ekman KT Britton (1994) ArticleTitleCorticotropin-releasing factor and neuropeptide Y: role in emotional integration Trends Neurosci 17 80–85 Occurrence Handle7512773 Occurrence Handle1:CAS:528:DyaK2cXhvVejtrY%3D

    PubMed  CAS  Google Scholar 

  • M Heilig S McLeod GK Koob KT Britton (1992) ArticleTitleAnxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test Regul Peptides 41 61–69 Occurrence Handle1:CAS:528:DyaK38Xmt1OjsrY%3D

    CAS  Google Scholar 

  • M Heilig B Söderpalm JA Engel E Widerlov (1989) ArticleTitleCentrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models Psychopharmacology 98 524–529 Occurrence Handle2570434 Occurrence Handle1:CAS:528:DyaL1MXlt1Ogtrs%3D

    PubMed  CAS  Google Scholar 

  • GL Hinks P Brown M Field JA Poat J Hughes (1996) ArticleTitleThe anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze Eur J Pharmacol 312 153–161 Occurrence Handle8894590 Occurrence Handle1:CAS:528:DyaK28XlvVags7g%3D

    PubMed  CAS  Google Scholar 

  • T Hökfelt C Broberger Z-QD Xu V Sergeyev R Ubink M Diez (2000) ArticleTitleNeuropeptides – an overview Neuropharmacology 39 1337–1356 Occurrence Handle10818251

    PubMed  Google Scholar 

  • T Hökfelt J Rehfeld L Skirboll B Ivemark M Goldstein K Markey (1980) ArticleTitleEvidence for co-existence for dopamine and CCK in mesolimbic neurons Nature 285 476–478 Occurrence Handle6105617

    PubMed  Google Scholar 

  • A Holmes M Heilig NMJ Rupniak T Steckler G Griebel (2003) ArticleTitleNeuropeptide systems as novel therapeutic targets for depression and anxiety disorders Trends Pharmacol Sci 24 580–588 Occurrence Handle14607081 Occurrence Handle1:CAS:528:DC%2BD3sXos12ks7o%3D

    PubMed  CAS  Google Scholar 

  • VG Hosing A Schirmacher G Kuhlenbaumer C Freitag P Sand C Schlesiger C Jacob J Fritze P Franke M Rietchel H Garritsen MM Nothen R Fimmers F Stogbauer J Deckert (2004) ArticleTitleCholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder J Neural Transm 68 147–156 Occurrence Handle1:CAS:528:DC%2BD2MXht1CgurfE

    CAS  Google Scholar 

  • J Hughes P Boden B Costall A Domeney E Kelly DC Horwell JC Hunter RD Pinnock GN Woodruff (1990) ArticleTitleDevelopment of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity Proc Natl Acad Sci USA 87 6728–6732 Occurrence Handle1975695 Occurrence Handle1:CAS:528:DyaK3cXmtVGhsrg%3D

    PubMed  CAS  Google Scholar 

  • NJT Johnson RJ Rodgers (1996) ArticleTitleEthological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice Psychopharmacology 124 355–364 Occurrence Handle8739551 Occurrence Handle1:CAS:528:DyaK28Xkslyisrc%3D

    PubMed  CAS  Google Scholar 

  • T Karl T Hoffmann R Pabst S von Hörsten (2003) ArticleTitleBehavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity Pharmacol Biochem Behav 75 869–879 Occurrence Handle12957230 Occurrence Handle1:CAS:528:DC%2BD3sXmvV2qsro%3D

    PubMed  CAS  Google Scholar 

  • A Kask M Eller L Oreland J Harro (2000) ArticleTitleNeuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat Neuropeptides 34 58–61 Occurrence Handle10688970 Occurrence Handle1:CAS:528:DC%2BD3cXit1egt7c%3D

    PubMed  CAS  Google Scholar 

  • A Kask J Harro (2000) ArticleTitleInhibition of amphetamine and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304 Neuropharmacology 39 1292–1302 Occurrence Handle10760371 Occurrence Handle1:CAS:528:DC%2BD3cXitlKku7k%3D

    PubMed  CAS  Google Scholar 

  • A Kask J Harro S von Hörsten P Redrobe Y Dumont R Quirion (2002) ArticleTitleThe neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y Neurosci Biobehav Rev 26 259–283 Occurrence Handle12034130 Occurrence Handle1:CAS:528:DC%2BD38XktVaku7s%3D

    PubMed  CAS  Google Scholar 

  • A Kask T Kivastik L Rägo J Harro (1999) ArticleTitleNeuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats Prog Neuro-Psychopharmacol Biol Psychiatry 23 705–711 Occurrence Handle1:CAS:528:DyaK1MXjvV2ltrs%3D

    CAS  Google Scholar 

  • A Kask HP Nguyen R Pabst S von Hörsten (2001) ArticleTitleNeuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone (CRH)-induced anxiety Neuroscience 104 799–806 Occurrence Handle11440811 Occurrence Handle1:CAS:528:DC%2BD3MXkvVegs7Y%3D

    PubMed  CAS  Google Scholar 

  • A Kask L Rägo J Harro (1996) ArticleTitleAnxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam Eur J Pharmacol 317 R3–R4 Occurrence Handle8997632 Occurrence Handle1:CAS:528:DyaK28XnsFSnt7o%3D

    PubMed  CAS  Google Scholar 

  • A Kask L Rägo J Harro (1997) ArticleTitleα-Helical CRF9–41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats Neuroreport 8 3645–3647 Occurrence Handle9427342 Occurrence Handle1:CAS:528:DyaK2sXnsVyqu78%3D

    PubMed  CAS  Google Scholar 

  • A Kask L Rägo J Harro (1998a) ArticleTitleAnxiolytic-like effects of NPY and NPY13–36 microinjected into vicinity of locus coeruleus in rats Brain Res 788 345–348 Occurrence Handle1:CAS:528:DyaK1cXhvVSisL0%3D

    CAS  Google Scholar 

  • A Kask L Rägo J Harro (1998b) ArticleTitleAnxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats Regul Peptides 75/76 255–262

    Google Scholar 

  • A Kask L Rägo J Harro (1998c) ArticleTitleNPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test Neuroreport 9 2713–2716 Occurrence Handle1:CAS:528:DyaK1cXmsVCmtr0%3D

    CAS  Google Scholar 

  • A Kask L Rägo J Harro (1998d) ArticleTitleEvidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226 Br J Pharmacol 124 1507–1515 Occurrence Handle1:CAS:528:DyaK1cXlsVWnu7o%3D

    CAS  Google Scholar 

  • PJ King PS Widdowson HN Doods G Williams (1999) ArticleTitleRegulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices J Neurochem 73 641–646 Occurrence Handle10428060 Occurrence Handle1:CAS:528:DyaK1MXkslOqsLw%3D

    PubMed  CAS  Google Scholar 

  • S Kõks A Soosaar V Võikar V Volke M Ustav PT Männistö M Bourin E Vasar (1998) ArticleTitleOpioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze Neuropeptides 32 325–340

    Google Scholar 

  • AS Kopin EW McBride C Chen RM Freidinger D Chen C-M Zhao M Beinborn (2003) ArticleTitleIdentification of a series of CCK-2 receptor nopeptide agonists: Sensitivity to stereochemistry and a receptor point mutation Proc Natl Acad Sci USA 100 5525–5530 Occurrence Handle12697901 Occurrence Handle1:CAS:528:DC%2BD3sXjs1yiurY%3D

    PubMed  CAS  Google Scholar 

  • MS Kramer NR Cutler JC Ballenger WM Patterson J Mendels A Chenaoult R Shrivastava D Matzura-Wolfe C Lines S Reines (1995) ArticleTitleA placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder Biol Psychiatry 37 462–466 Occurrence Handle7786960 Occurrence Handle1:STN:280:DyaK2Mzgs1GmtQ%3D%3D

    PubMed  CAS  Google Scholar 

  • N Ladurelle BP Roques V Daugé (1995) ArticleTitleThe transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens J Neurosci 15 3118–3127 Occurrence Handle7722650 Occurrence Handle1:CAS:528:DyaK2MXltVOit7s%3D

    PubMed  CAS  Google Scholar 

  • D Larhammar E Salaneck (2004) ArticleTitleMolecular evolution of NPY receptor sybtypes Neuropeptides 38 141–151 Occurrence Handle15337367 Occurrence Handle1:CAS:528:DC%2BD2cXntVOjsLg%3D

    PubMed  CAS  Google Scholar 

  • C Lines J Challenor M Traub (1995) ArticleTitleCholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260 Br J Clin Pharmacol 39 235–242 Occurrence Handle7619662 Occurrence Handle1:CAS:528:DyaK2MXkvVGmsbs%3D

    PubMed  CAS  Google Scholar 

  • C Löfberg H Ågren J Harro L Oreland (1998) ArticleTitleCholecystokinin in the CSF from depressed patients: possible relations to severity of depression and suicidal behaviour Eur Neuropsychopharmacol 8 153–157 Occurrence Handle9619694

    PubMed  Google Scholar 

  • RB Lydiard JC Ballenger MT Laraia MD Fossey MC Beinfeld (1992) ArticleTitleCSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects Am J Psychiatry 149 691–693 Occurrence Handle1575262 Occurrence Handle1:STN:280:DyaK383ks1ahsA%3D%3D

    PubMed  CAS  Google Scholar 

  • E Maron T Nikopensius S Kõks S Altmäe E Heinaste K Vabrit V Tammekivi P Hallast K Koido A Kurg A Metspalu E Vasar V Vasar J Shlik (2005) ArticleTitleAssociation study of 90 candidate gene polymorphisms in panic disorder Psych Genet 15 17–24

    Google Scholar 

  • G Marsicano B Lutz (1999) ArticleTitleExpression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 4213–4225 Occurrence Handle10594647 Occurrence Handle1:STN:280:DC%2BD3c%2Fmt1Crug%3D%3D

    PubMed  CAS  Google Scholar 

  • JL Marx (1985) ArticleTitle“Anxiety peptide” found in brain Science 227 934 Occurrence Handle2982215 Occurrence Handle1:STN:280:DyaL2M7hsFeruw%3D%3D

    PubMed  CAS  Google Scholar 

  • V Matto J Harro L Allikmets (1997) ArticleTitleThe effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat Neuropharmacology 36 389–396 Occurrence Handle9175618 Occurrence Handle1:CAS:528:DyaK2sXjtlOmsbk%3D

    PubMed  CAS  Google Scholar 

  • CC Miller PV Holmes GL Edwards (2002) ArticleTitleArea postrema lesions elevate NPY levels and decrease anxiety-related behavior in rats Physiol Behav 77 135–140 Occurrence Handle12213511 Occurrence Handle1:CAS:528:DC%2BD38Xms12gs7c%3D

    PubMed  CAS  Google Scholar 

  • CF Netto FS Guimaraes (2004) ArticleTitleAnxiogenic effect of cholecystokinin in the dorsal periaqueductal grey Neuropsychopharmacology 29 101–107 Occurrence Handle14583742

    PubMed  Google Scholar 

  • AC Pande M Greiner JB Adams RB Lydiard MW Pierce (1999) ArticleTitlePlacebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder Biol Psychiatry 46 860–862 Occurrence Handle10494457 Occurrence Handle1:CAS:528:DyaK1MXmtVOqtbs%3D

    PubMed  CAS  Google Scholar 

  • J Panksepp (1986) ArticleTitleThe neurochemistry of behavior Ann Rev Psychol 37 77–107 Occurrence Handle1:STN:280:DyaL287osFeqsQ%3D%3D

    CAS  Google Scholar 

  • J Panksepp (1998) Affective neuroscience Oxford University Press New York Oxford

    Google Scholar 

  • J Panksepp J Burgdorf MC Beinfeld RA Kroes JR Moskal (2004) ArticleTitleRegional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats Brain Res 1025 75–84 Occurrence Handle15464747 Occurrence Handle1:CAS:528:DC%2BD2cXotFSiurc%3D

    PubMed  CAS  Google Scholar 

  • J Panksepp J Harro (2004) Future of neuropeptides in biological psychiatry and emotional psychopharmacology: goals and strategies J Panksepp (Eds) Textbook of biological psychiatry Wiley New York 627–659

    Google Scholar 

  • GD Philips J Le Noury G Wolterink I Donselaar-Wolterink TW Robbins BJ Everitt (1993) ArticleTitleCholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement Behav Brain Res 55 223–231

    Google Scholar 

  • PV Piazza F Rouge-Pont JM Deminiere M Kharoubi M Le Moal H Simon (1991) ArticleTitleDopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration Brain Res 567 169–174 Occurrence Handle1726140 Occurrence Handle1:STN:280:DyaK383nsVWkug%3D%3D

    PubMed  CAS  Google Scholar 

  • JA Pratt RR Brett (1995) ArticleTitleThe benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain Neurosci Lett 184 197–200 Occurrence Handle7715845 Occurrence Handle1:CAS:528:DyaK2MXjs1GgtLc%3D

    PubMed  CAS  Google Scholar 

  • SD Primeaux SP Wilson MC Cusick DA York MA Wilson (2005) ArticleTitleEffects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors Neuropsychopharmacology 30 1589–1597 Occurrence Handle15770236 Occurrence Handle1:CAS:528:DC%2BD2MXotFegtbg%3D

    PubMed  CAS  Google Scholar 

  • D Radu A Ahlin P Svanborg N Lindefors (2003) ArticleTitlePentagastrin test for anxiety – psychophysiology and personality Psychopharmacology 166 139–145 Occurrence Handle12529809 Occurrence Handle1:CAS:528:DC%2BD3sXhsVSltbc%3D

    PubMed  CAS  Google Scholar 

  • D Radu E Brodin G Weber N Lindefors (2001) ArticleTitleDelayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine Brain Res 908 197–203 Occurrence Handle11454330 Occurrence Handle1:CAS:528:DC%2BD3MXltVejsr8%3D

    PubMed  CAS  Google Scholar 

  • L Rägo R-A Kiivet J Harro M Põld (1988) ArticleTitleBehavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex Naunyn-Schmiedeberg’s Arch Pharmacol 337 675–678

    Google Scholar 

  • M Rattray S Singhvi PY Wu N Andrews SE File (1993) ArticleTitleBenzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain Eur J Pharmacol 245 193–196 Occurrence Handle8491257 Occurrence Handle1:CAS:528:DyaK3sXkt1Sgur0%3D

    PubMed  CAS  Google Scholar 

  • JP Redrobe Y Dumont A Fournier R Quirion (2003) ArticleTitleNeuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice Behav Brain Res 141 251–255 Occurrence Handle12742262 Occurrence Handle1:CAS:528:DC%2BD3sXjsVWlsrg%3D

    PubMed  CAS  Google Scholar 

  • JP Redrobe Y Dumont R Quirion (2002) ArticleTitleNeuropeptide Y (NPY) and depression: From animal models to the human condition Life Sci 71 2921–2937 Occurrence Handle12384178 Occurrence Handle1:CAS:528:DC%2BD38XnvVKmtr4%3D

    PubMed  CAS  Google Scholar 

  • J Rehfeld (1985) ArticleTitleNeuronal cholecystokinin: one or multiple neurotransmitters? J Neurochem 44 1–10 Occurrence Handle2856882 Occurrence Handle1:CAS:528:DyaL2MXjvF2ksw%3D%3D

    PubMed  CAS  Google Scholar 

  • J Rehfeld (1992) CCK and anxiety: Introduction CT Dourish SJ Cooper SD Iversen LL Iversen (Eds) Multiple cholecystokinin receptors in the CNS Oxford University Press New York 117–120

    Google Scholar 

  • A Rex CA Marsden H Fink (1994) ArticleTitleEffects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze Neuropharmacology 33 559–565 Occurrence Handle7527129 Occurrence Handle1:CAS:528:DyaK2cXktlans70%3D

    PubMed  CAS  Google Scholar 

  • A Rinken J Harro L Engström L Oreland (1998) ArticleTitleRole of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8s to rat brain cortical membranes Biochem Pharmacol 55 423–431 Occurrence Handle9514076 Occurrence Handle1:CAS:528:DyaK1cXmsVyqsw%3D%3D

    PubMed  CAS  Google Scholar 

  • T Sajdyk DA Schober DR Gehlert (2002) ArticleTitleNeuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats Neuropharmacology 43 1165–1172 Occurrence Handle12504923 Occurrence Handle1:CAS:528:DC%2BD38Xps12lsrk%3D

    PubMed  CAS  Google Scholar 

  • T Sajdyk A Shekhar DR Gehlert (2004) ArticleTitleInteractions between NPY and CRF in the amygdala to regulate emotionality Neuropeptides 38 225–234 Occurrence Handle15337374 Occurrence Handle1:CAS:528:DC%2BD2cXntVOjsb0%3D

    PubMed  CAS  Google Scholar 

  • T Sajdyk MG Vandergriff DR Gehlert (1999) ArticleTitleAmygdalar neuropeptide Y Y-1 receptors mediate the anxiolytic actions of neuropeptide Y in the social interaction test Eur J Pharmacol 368 143–147 Occurrence Handle10193650 Occurrence Handle1:CAS:528:DyaK1MXhs1Oit7w%3D

    PubMed  CAS  Google Scholar 

  • H Schreiber G Stolz-Born R Pietrowsky HH Kornhuber HL Fehm J Born (1995) ArticleTitleImproved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons Biol Psychiatry 37 702–712 Occurrence Handle7640325 Occurrence Handle1:CAS:528:DyaK2MXmtlGrtL8%3D

    PubMed  CAS  Google Scholar 

  • T Sherrin KYC H YZ Zhu YM Tang G Lau CH Tan (2004) ArticleTitleCholecystokinin-B receptor gene expression in cerebellum, pre-frontal cortex and cingulate gyrus and its association with suicide Neurosci Lett 357 107–110 Occurrence Handle15036586 Occurrence Handle1:CAS:528:DC%2BD2cXhsVKhtrs%3D

    PubMed  CAS  Google Scholar 

  • PD Shilling D Feifel (2002) ArticleTitleSR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI Psychopharmacology 164 285–293 Occurrence Handle12424552 Occurrence Handle1:CAS:528:DC%2BD38XosFWgt7w%3D

    PubMed  CAS  Google Scholar 

  • N Singewald T Sharp (2000) ArticleTitleNeuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry Neuroscience 98 459–470

    Google Scholar 

  • L Singh AS Lewis MJ Field J Hughes GN Woodruff (1991) ArticleTitleEvidence for an involvement of the brain cholecystokinin B receptor in anxiety Proc Natl Acad Sci USA 88 1130–1133 Occurrence Handle1996314 Occurrence Handle1:CAS:528:DyaK3MXhtlKgtb4%3D

    PubMed  CAS  Google Scholar 

  • G Sorensen C Lindberg G Wortwein TG Bolwig DP Woldbye (2004) ArticleTitleDifferential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation J Neurosci Res 77 723–729 Occurrence Handle15352219 Occurrence Handle1:CAS:528:DC%2BD2cXnsVKmt7k%3D

    PubMed  CAS  Google Scholar 

  • PE Sullivan KS Kendler (1998) ArticleTitleTypology of common psychiatric syndromes. An empirical study Br J Psychiatry 173 312–319 Occurrence Handle9926035 Occurrence Handle1:STN:280:DyaK1M7isVymug%3D%3D Occurrence Handle10.1192/bjp.173.4.312

    Article  PubMed  CAS  Google Scholar 

  • M Suzuki CT Beuckmann K Shikata H Ogura T Sawai (2005) ArticleTitleOrexin-1 (hypocretin-1) is possibly involved in generation of anxiety-like behavior Brain Res 1044 116–121 Occurrence Handle15862796 Occurrence Handle1:CAS:528:DC%2BD2MXjvVOiu70%3D

    PubMed  CAS  Google Scholar 

  • A Thorsell K Carlsson R Ekman M Heilig (1999) ArticleTitleBehavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress Neuroreport 10 3003–3007 Occurrence Handle10549813 Occurrence Handle1:CAS:528:DyaK1MXmsl2hs7o%3D

    PubMed  CAS  Google Scholar 

  • A Thorsell M Michalkiewicz Y Dumont R Quirion L Caberlotto R Rimondini AA Mathe M Heilig (2000) ArticleTitleBehavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression Proc Natl Acad Sci USA 97 12852–12857 Occurrence Handle11058155 Occurrence Handle1:CAS:528:DC%2BD3cXotFyks70%3D

    PubMed  CAS  Google Scholar 

  • A Thorsell P Svensson L Wiklund W Sommer R Ekman M Heilig (1998) ArticleTitleSuppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress Regul Peptides 75/76 247–254

    Google Scholar 

  • CT To G Bagdy (1999) ArticleTitleAnxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment Neuropharmacology 38 279–282 Occurrence Handle10218869 Occurrence Handle1:CAS:528:DyaK1MXhvVOqtrc%3D

    PubMed  CAS  Google Scholar 

  • P Tovote M Meyer A Beck-Sickinger S von Hörsten SO Ögren J Spiess O Stiedl (2004) ArticleTitleCentral NPY receptor-mediated alteration of heart dynamics in mice during expression of fear conditioned to an auditory cue Regul Peptides 120 205–214 Occurrence Handle1:CAS:528:DC%2BD2cXks1Wku70%3D

    CAS  Google Scholar 

  • A Tschenett N Singewald M Carli C Balducci P Salchner A Vezzani H Herzog G Sperk (2003) ArticleTitleReduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors Eur J Neurosci 18 143–148 Occurrence Handle12859347

    PubMed  Google Scholar 

  • N Tsujino A Yamanaka K Ichiki Y Muraki TS Kilduff K-I Yagami S Takahashi K Goto T Sakurai (2005) ArticleTitleCholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor J Neurosci 25 7459–7469 Occurrence Handle16093397 Occurrence Handle1:CAS:528:DC%2BD2MXpsFGiu70%3D

    PubMed  CAS  Google Scholar 

  • HJGM Van Megen HGM Westenberg JA den Boer JRM Haigh M Traub (1994) ArticleTitlePentagastrin-induced panic attacks: Enhanced sensitivity in panic disorder patients Psychopharmacology 114 449–455 Occurrence Handle7855203 Occurrence Handle1:CAS:528:DyaK2cXjtFKgsrc%3D

    PubMed  CAS  Google Scholar 

  • HJGM Van Megen HGM Westenberg JA den Boer B Slaap F van Es-Radhakistun AC Pande (1997) ArticleTitleThe cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients Psychopharmacology 129 243–248 Occurrence Handle9084062 Occurrence Handle1:CAS:528:DyaK2sXhsVCrtLs%3D

    PubMed  CAS  Google Scholar 

  • C Wahlestedt EM Pich GF Koob F Yee M Heilig (1993) ArticleTitleModulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides Science 259 528–531 Occurrence Handle8380941 Occurrence Handle1:CAS:528:DyaK3sXhsVSlsb8%3D

    PubMed  CAS  Google Scholar 

  • D Wahlsten P Metten TJ Phillips SL Boehm Suffix2nd S Burkhart-Kasch J Dorow S Doerksen C Downing J Fogarty K Rodd-Henricks R Hen CS McKinnon CM Merrill C Nolte M Schalomon JP Schlumbohm JR Sibert CD Wenger BC Dudek JC Crabbe (2003) ArticleTitleDifferent data from different labs: lessons from studies of gene-environment interaction J Neurobiol 54 283–311 Occurrence Handle12486710

    PubMed  Google Scholar 

  • H Wang PTH Wong J Spiess YZ Zhu (2005) ArticleTitleCholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats Neurosci Biobehav Rev 29 1361–1373 Occurrence Handle16120463 Occurrence Handle1:CAS:528:DC%2BD2MXhtFeiurfL

    PubMed  CAS  Google Scholar 

  • H Wang YZ Zhu JM Farook S Moochala AL Teo LK Lee PTH Wong (2003) ArticleTitleGenetic variations in CCK2 receptor in PVG hooded and Sprague–Dawley rats and its mRNA expression on cat exposure Behav Neurosci 117 385–390 Occurrence Handle12708535 Occurrence Handle1:CAS:528:DC%2BD3sXivFeht7g%3D

    PubMed  CAS  Google Scholar 

  • A Westrin R Ekman Träskman-Bendz (1999) ArticleTitleAlterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt Eur Neuropsychopharmacol 9 205–211 Occurrence Handle10208289 Occurrence Handle1:CAS:528:DyaK1MXhsVWntL0%3D

    PubMed  CAS  Google Scholar 

  • PS Widdowson GA Ordway AE Halaris (1992) ArticleTitleReduced neuropeptide Y concentrations in suicide brain J Neurochem 59 73–80 Occurrence Handle1613514 Occurrence Handle1:CAS:528:DyaK38Xks1eksbY%3D

    PubMed  CAS  Google Scholar 

  • EP Wiertelak SF Maier LR Watkins (1992) ArticleTitleCholecystokinin antianalgesia: Safety cues abolish morphine analgesia Science 256 830–833 Occurrence Handle1589765 Occurrence Handle1:CAS:528:DyaK38Xkt1Srt7w%3D

    PubMed  CAS  Google Scholar 

  • GR Wunderlich NJ DeSousa FJ Vaccarino (2000) ArticleTitleCholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat Psychopharmacology 151 283–290 Occurrence Handle10972475 Occurrence Handle1:CAS:528:DC%2BD3cXmtFyksLg%3D

    PubMed  CAS  Google Scholar 

  • GR Wunderlich R Raymond NJ DeSousa JN Nobrega FJ Vaccarino (2002) ArticleTitleDecreased CCKB receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior Psychopharmacology 164 193–199 Occurrence Handle12404082 Occurrence Handle1:CAS:528:DC%2BD38Xot1Ciurk%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology and Psychopharmacological Drug Development Group, Centre of Behavioural and Health Sciences, University of Tartu, Tartu, Estonia

    J. Harro

Authors
  1. J. Harro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harro, J. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies. Amino Acids 31, 215–230 (2006). https://doi.org/10.1007/s00726-006-0334-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-006-0334-x

Search

Navigation